Medline Inc. Completes IPO and Amends Corporate Governance

Summary

Medline Inc. has successfully completed its initial public offering (IPO) on December 18, 2025, raising $7.2 billion net of underwriting discounts. The company used the proceeds to repay outstanding debts and for general corporate purposes. Simultaneously, Medline Inc. amended its Certificate of Incorporation and Bylaws, and appointed Todd M. Bluedorn to its Board of Directors. Additionally, the company adopted new incentive and stock purchase plans for its employees.